Involvement of oxidative pathways and BDNF in the antidepressant effect of carvedilol in a depression model induced by chronic unpredictable stress
- 13 January 2022
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 239 (1) , 297-311
Abstract
Rationale Depression is a severe psychiatric disorder with oxidative imbalance and neurotrophic deficits as underlying mechanisms. Objectives Based on the antioxidant effects of carvedilol (CARV), here, we aimed to evaluate CARV’s effects against depression induced by the chronic unpredictable stress (CUS) model. Methods Female Swiss mice were submitted to the CUS protocol for 21 days. Between days 15 and 22, the animals received CARV (5 or 10 mg/kg) or desvenlafaxine (DVS 10 mg/kg) orally. On the 22nd day, mice were subjected to behavioral tests to evaluate locomotion, depressive-like behavior (tail suspension test), motivation/self-care with the splash test (ST), social interaction, and working memory Y-maze test. The prefrontal cortex (PFC) and hippocampus were dissected to evaluate alterations of oxidative and brain-derived neurotrophic factor (BDNF). Results The CUS model reduced locomotion and increased grooming latency, while it reduced the number of groomings in the ST. Both doses of CARV and DVS reverted these alterations. In addition, DVS and CARV reversed CUS model–induced working memory and social interaction deficits. The CUS model decreased hippocampal reduced glutathione (GSH), while DVS and CARV increased GSH in the PFC (CARV5) and hippocampus (CARV5 and 10). The CUS model increased nitrite and malondialdehyde (MDA) concentrations in both areas. All treatments reversed nitrite alterations, while CARV10 changed MDA levels in PFC and all treatments in the hippocampus. The CUS model reduced BDNF levels. CARV10 increased BDNF in the PFC, while both doses of CARV increased hippocampal levels of this neurotrophin. Conclusions CARV presents antidepressant-like effects comparable to those observed with DVS. In addition, it has an antioxidant effect and is capable of increasing BDNF brain concentrations. Further studies are needed to elucidate the mechanisms involved in the antidepressant effect of CARV.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação Cearense de Apoio ao Desenvolvimento Científico e Tecnológico
This publication has 92 references indexed in Scilit:
- Carvedilol Decrease IL-1β and TNF-α, Inhibits MMP-2, MMP-9, COX-2, and RANKL Expression, and Up-Regulates OPG in a Rat Model of PeriodontitisPLOS ONE, 2013
- Carvedilol as a potential novel agent for the treatment of Alzheimer's diseaseNeurobiology of Aging, 2011
- A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illnessProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2011
- Neuroprotective effect of carvedilol, an adrenergic antagonist against colchicine induced cognitive impairment and oxidative damage in ratPharmacology Biochemistry and Behavior, 2009
- The molecular neurobiology of depressionNature, 2008
- Dose translation from animal to human studies revisitedThe FASEB Journal, 2007
- Morphological Correlates of Corticosteroid-Induced Changes in Prefrontal Cortex-Dependent BehaviorsJournal of Neuroscience, 2005
- Chronic Mild Stress (CMS) Revisited: Consistency and Behavioural-Neurobiological Concordance in the Effects of CMSNeuropsychobiology, 2005
- Associação entre sintomas depressivos e funcionamento social em cuidados primários à saúdeRevista de Saúde Pública, 2002
- Neuroprotective effects of carvedilol, a new antihypertensive agent, in cultured rat cerebellar neurons and in gerbil global brain ischemia.Stroke, 1992